Study of Hip and Knee Arthroplasty in South Africa
Prospective Observational Study of Current Perioperative Care for Hip and Knee Arthroplasty in South Africa, and Associated Outcomes
1 other identifier
observational
206
1 country
9
Brief Summary
This multi-site, observational, prospective study aims to investigate current practice and associated outcomes for patients scheduled for elective unilateral total hip or knee arthroplasty in South Africa.This information will provide baseline values, against which effects of implementing a multidisciplinary enhanced care protocol for arthroplasty patients will be compared (the subsequent study).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2018
Shorter than P25 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2018
CompletedStudy Start
First participant enrolled
May 7, 2018
CompletedFirst Posted
Study publicly available on registry
May 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2019
CompletedAugust 18, 2020
August 1, 2020
9 months
May 4, 2018
August 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
"Days alive and at home 30 days after surgery" (DAH30)
A patient centered measure which integrates length of hospital stay, readmission due to postoperative complications, discharge destination and early death after surgery . This outcome is an overall measure of the recovery profile as it captures much of the surgical experience, integrating efficacy, quality and safety thus reflecting value based care and actions. As such, DAH30 is transparent and can be used for benchmarking performance of quality of perioperative care.
30 days
Secondary Outcomes (7)
Timed Up and Go test
2-5 days after surgery
EQ-5D
30 days and 1 year after surgery
EQ-VAS
30 days and 1 year after surgery
Satisfaction with surgery
30 days and 1 year after surgery
1-year incidence of mortality
1 year follow up
- +2 more secondary outcomes
Study Arms (1)
Single group study
The study population will include patients presenting for primary elective unilateral total hip and knee arthroplasty.
Eligibility Criteria
All patients scheduled for primary elective unilateral total hip or knee arthroplasty.
You may qualify if:
- All patients scheduled for primary elective unilateral total hip or knee arthroplasty in the 10 week study period at the 10 participating study sites in South Africa.
- Patients must accept to be contacted telephonically 30 days and 12 months after surgery.
You may not qualify if:
- Patients who do not have a mobile telephone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Universitas Academic Hospital
Bloemfontein, Free State, 9300, South Africa
Steve Biko Academic Hospital
Pretoria, Gauteng, 0001, South Africa
Albert Luthuli Central Hospital
Durban, KwaZulu-Natal, 4058, South Africa
Grey's Hospital
Pietermaritzburg, KwaZulu-Natal, 3200, South Africa
Mitchells Plain Hospital
Cape Town, Western Cape, 7599, South Africa
Somerset Hospital
Cape Town, Western Cape, 7599, South Africa
Victoria Hospital
Cape Town, Western Cape, 7599, South Africa
Groote Schuur Hospital
Cape Town, Western Cape, 7700, South Africa
Paarl Hospital
Paarl, Western Cape, 7599, South Africa
Related Publications (1)
Plenge U, Parker R, Davids S, Davies GL, Fullerton Z, Gray L, Groenewald P, Isaacs R, Kauta N, Louw FM, Mazibuko A, North DM, Nortje M, Nunes GM, Pebane N, Rajah C, Roos J, Ryan P, September WV, Shanahan H, Siebritz RE, Smit RW, Sombili S, Torborg A, van der Merwe JF, van der Westhuizen N, Biccard B. Quality of recovery after total hip and knee arthroplasty in South Africa: a national prospective observational cohort study. BMC Musculoskelet Disord. 2020 Nov 5;21(1):721. doi: 10.1186/s12891-020-03752-x.
PMID: 33153453DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ulla Plenge, MD
University of Cape Town
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Researcher
Study Record Dates
First Submitted
May 4, 2018
First Posted
May 30, 2018
Study Start
May 7, 2018
Primary Completion
January 30, 2019
Study Completion
January 30, 2019
Last Updated
August 18, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share